References
- Adlercreutz H., Salmi H. J., Soininen K., Härkönen M. Determination of α-amylase in serum and urine of subjects with a low bicarbonate concentration in the duodenal aspirate after secretin stimulation. Clin. chim. Acta. 1973; 42: 187
- Berger G. M. B., Liesching W. Interbatch variability in measurement of urinary amylase with a commercial kit. Clin. Chem. 1976; 22: 556
- Ceska M., Birath K., Brown B. A new and rapid method for the clinical determination of α-amylase activities in human serum and urine. Optimal conditions. Clin. chim. Acta 1969; 26: 437
- Ceska M., Brown B., Birath K. Ranges of α-amylase activities in human serum and urine and correlations with some other α-amylase methods Clin. chim. Acta 1969; 26: 445
- Hall F. F., Ratliff C. R., Hightower N. C. Chromogenic amylase methods. Clin. Chem. 1972; 18: 689
- Hamlin C. R., Schwede K. Standardization of an alpha-amylase kit procedure. Clin. Chem. 1974; 20: 96
- Irie A., Hunaki M., Bando K., Kawai K. Determination of amylase activity in serum and urine using blue starch substrate. Clin. chim. Acta 1972; 42: 63
- Mazzuchin A., Weggel C., Porter C. J. Automated method for determining amylase activity in serum and urine. Clin. Chem. 1973; 19: 1187
- Melnychuk A. Serum amylase. A comparison of a saccharogenic and four commercial dye-substrate methods. Canad. J. Med. Technol. 1973; 35: 9
- Ojala K., Harmoinen A. Determination of amylase activity and amylase isoenzymes in serum and urine using a solid phase blue starch substrate. Scand. J. clin. Lab. Invest. 1975; 35: 163
- Rönnemaa T., Nanto V. Determination of amylase in biological fluids of low protein concentration. Scand. J. clin. Lab. Invest. 1971; 27: 25
- Skude G. Micromodification of the Phadebas® amylase test. Scand. J. clin. Lab. Invest. 1976; 36: 399
- Soininen K., Harkonen M., Ceska M., Adlercreutz H. Comparison between a new chromogenic α-amylase test (Phadebas) and the Wohlgemuth amyloclastic method in urine. Scand. J. clin. Lab. Invest. 1972; 30: 291